Showing results (1171-1180 of 9,422) with videos related to
Sort By:
Pageof 943
Clinical Endocrinology|April 24, 2004
Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?Chandrika N Wijeyaratne, K Nirantharakumar, Adam H Balen, et al.Clinical Endocrinology|April 24, 2004
Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up studyNienke R Biermasz, Neveen A T Hamdy, Alberto M Pereira, et al.Clinical Endocrinology|April 24, 2004
Neuroendocrine dysfunction in the acute phase of traumatic brain injuryAmar Agha, Bairbre Rogers, Darren Mylotte, et al.Clinical Endocrinology|April 24, 2004
Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic diseaseS Y Goh, S C Ho, L L Seah, et al.Clinical Endocrinology|April 24, 2004
Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissuesVirgil A S H Dalm, P Martin Van Hagen, Ronald R de Krijger, et al.Clinical Endocrinology|August 25, 2005
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerMingzhao XingClinical Endocrinology|May 1, 1992
Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretionH P Koppeschaar, C D ten Horn, J H Thijssen, et al.Clinical Endocrinology|August 25, 2005
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trialI M M J Wakelkamp, L Baldeschi, P Saeed, et al.Clinical Endocrinology|August 25, 2005
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegalyAnnamaria Colao, Rosario Pivonello, Paolo Cappabianca, et al.Clinical Endocrinology|September 27, 2005
Psychosocial morbidity of Graves' orbitopathyG J Kahaly, F Petrak, J Hardt, et al.Pageof 943